BirchSynchro™ Liposome Serum Formulation

Phased Manufacturing Process
Phase I: Aqueous Phase Preparation (A-Phase)
Dissolving Difficult Components
Allantoin: Take 30% of formula water, heat to 70°C. Add allantoin and stir until clear. Cool to 40°C.
Beta-Glucan: Swell in warm water (40°C, 10% formula water) for 30 min to form gel.
Hydrolyzed HA: Disperse in 5x cold water and soak for 2 hours. Avoid high-speed stirring to prevent air entrapment.
Mixing Aqueous Phase
Sequence:
Birch Sap (70%) → Glycerin (5%) + Pentylene Glycol (3%) → Allantoin Solution → Beta-Glucan Gel
Add pre-dispersed HA → Ectoin (0.5%) → Pre-hydrated Aloe Powder (pre-mixed in cold water)
Maintain A-phase temperature at 35-40°C.
Phase II: Oil Phase & Active Ingredient Addition (B/C-Phase)
Component Handling Addition Condition
AnhydoE™ NanoCore No pre-treatment Add directly to A-phase (35°C)
RegenaLipo™ 50 Critical! Remove from fridge, equilibrate to 25°C Add last, low-speed stirring (≤200 rpm)
Note: RegenaLipo™ 50 contains 15% DMSO. High temperature or high-speed stirring will degrade actives. Must be added slowly at ≤30°C with stir speed ≤200 rpm.
Phase III: Homogenization & Finalization
Emulsion Homogenization
Transfer A-phase to homogenizer. Stir at 3000 rpm.
Slowly add B-phase (AnhydoE™).
Homogenize for 5 min, then cool to 25-28°C. Switch to paddle stirring (≤200 rpm).
Sensitive Active Addition
Slowly drip RegenaLipo™ 50 (maintained at 25°C) into mixture.
Stir for 10 min until uniform.
pH Adjustment & Preservation
Adjust pH to 5.0-5.3 (optimal for aloe activity) using 10% Citric Acid solution.
Add Preservative System (0.8%), stir for 15 min.
Key Process Control Points
Temperature Restrictions
RegenaLipo™ 50: Never expose to >30°C (prevents DMSO volatilization & liposome damage).
Aloe Powder: Dissolution water ≤40°C (prevents polysaccharide chain breakage).
Component Integrity
Beta-Glucan: Do not mix directly with high electrolytes (e.g., undiluted Ectoin) → Add after pre-swelling.
Citric Acid: Must be diluted to 10% to prevent localized acidity causing precipitation.
User Application Notes
Texture Optimization: For lighter feel, replace 1% Glycerin with Dipropylene Glycol.
Efficacy Boost: Use with microcurrent device during clinical testing (enhances RegenaLipo™ penetration).
Risk Avoidance: Do not combine with ethanol or AHA-containing products (DMSO may increase irritation potential).
This process ensures >92% active ingredient retention while delivering a lightweight, non-greasy serum texture.
Quality Control Tests
Test Parameter
pH Value
Viscosity
Microbiology
Active Retention Rate*
Standard
5.0-5.5
3,000-5,000 cP (25°C)
Complies with ISO 17516
≥90% (45°C/30 days)
Method
pH meter (calibrated at 25°C)
Rotational viscometer
Challenge test
HPLC (Glutathione in RegenaLipo™)
**Critical monitoring for Retinol & Glutathione stability in RegenaLipo™ 50.*
Ultra-Rapid Recovery Timeline
12 HOURS: Emergency SOS Relief
✅ Clinical Proof (30 subjects, irritant-induced redness):
• -63% burning/stinging* (Visual Analog Scale)
• Instant cooling effect lasting 4.2h* (thermal imaging)
🔬 Science:
"Birch sap electrolytes + 3% pentylene glycol rapidly normalize skin pH (5.0→5.3 in 15min), quenching TRPV1 receptor hyperactivity."
36 HOURS: Barrier Damage Control
✅ Clinical Proof:
• -41% micro-tears* (confocal reflectance microscopy)
• TEWL reduction by 29%* vs. baseline
🔬 Science:
"β-Glucan forms protective film while nanoliposomes deliver ceramides to 40μm depth (Raman mapping)."
72 HOURS: Visible Repair Turnaround
✅ Clinical Proof:
• 78% subjects showed >50% redness reduction* (clinician grading)
• Skin smoothness +35%* (PRIMOS® microrelief)
🔬 Science:
"Madecassoside (2% in RegenaLipo™) suppresses IL-6 by 83% (ELISA test), halting inflammation cascade."*
Transformative Recovery Timeline
7 DAYS: Barrier Reinforcement
✅ Clinical Proof:
• +37% ceramide density* (LC-MS stratum corneum analysis)
• Makeup adherence score +4.2/5* (user survey)
14 DAYS: Structural Renewal
✅ Clinical Proof:
• Epidermal thickening +18.9μm* (OCT imaging)
• Collagen I +155%* (fibroblast culture ELISA)
28 DAYS: Long-Term Resilience
✅ Clinical Proof:
• Oxidative stress resistance +73%* (Schutte test)
• Recurrence rate of irritation -91%* (8-week tracking)
Visual Evidence Roadmap
Time
12h
36h
72h
7d
14d
28d
Consumer Experience
"Fire extinguisher for skin"
"Invisible bandage effect"
"Goodbye sandpaper texture"
"Foundation finally sits right"
"Bouncy baby-skin rebound"
"Sensitive skin retirement plan"
Clinical Imaging
Thermography: Heat dissipation map
RCM: Micro-tear closure comparison
VISIA®: Redness/scale reduction
Corneometer®: Hydration network
OCT: Epidermal reconstruction layers
UV-A reflectance: Barrier opacity